An oligonucleotide mixture for improved detection of human papillomavirus genotypes
Cervical cancer (cancer of the uterine cervix) is the second most common cancer among women worldwide with about 470,000 newly diagnosed cases and almost 250,000 deaths every year. The predominant cause for cervical cancer is infection of the cervix with human papillomavirus (HPV), particularly with high-risk HPV genotypes.
The identification of specific HPV genotypes is important, as various HPV genotypes and multiple infections pose different risks to the affected pa-tients. HPV DNA tests are detecting ongoing infections and cervical lesions but their specificity for ab-sence disease is low. In contrast, high viral load was shown to improve the specificity significantly. There is a need for more reliable tests detecting and quantifying different human papillomavirus (HPV) genotypes and, in particular, the high-risk and putative high-risk genotypes.
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Bringing bio-inspired robots to life
Nebraska researcher Eric Markvicka gets NSF CAREER Award to pursue manufacture of novel materials for soft robotics and stretchable electronics. Engineers are increasingly eager to develop robots that mimic the…
Bella moths use poison to attract mates
Scientists are closer to finding out how. Pyrrolizidine alkaloids are as bitter and toxic as they are hard to pronounce. They’re produced by several different types of plants and are…
AI tool creates ‘synthetic’ images of cells
…for enhanced microscopy analysis. Observing individual cells through microscopes can reveal a range of important cell biological phenomena that frequently play a role in human diseases, but the process of…
